Biomarker Discovery Market to Grow at 11.9% CAGR Driven by Multi-Omics, Precision Medicine & Companion Diagnostics

According to DataM Intelligence, the global biomarker discovery market size reached US$ 17.84 Billion in 2023 with a rise of US$ 19.80 Billion in 2024 and is expected to reach US$ 54.19 Billion by 2033, growing at a CAGR of 11.9% from 2025 to 2033. Growth is driven by advancements in multi-omics technologies, rising demand for precision medicine and companion diagnostics, increasing adoption of high-throughput screening and next-generation sequencing, and expanding applications in drug discovery and personalized treatment.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/biomarker-discovery-market?sindhuri

North America Key Industry Developments
✅ May 2025: Fujirebio received FDA 510(k) clearance for Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio test, advancing blood-based biomarker detection for Alzheimer's disease.
✅ Ongoing: High R&D investments and regulatory support driving adoption of omics-based technologies in the U.S.

Asia-Pacific Key Industry Developments
✅ September 2024: Amoy Diagnostics received NMPA approval for AmoyDx Pan Lung Cancer PCR Panel, enhancing biomarker detection for NSCLC mutations.
✅ Ongoing: Government initiatives and rising investments in precision medicine and omics research in China and India.

Key Mergers and Acquisitions (Recent)
✅ August 2024: Hitachi High-Tech partnered with Gencurix for cancer molecular diagnostics, leveraging biomarker discovery capabilities.
✅ January 2024: Genialis collaborated with Debiopharm for predictive biomarker identification in DNA damage repair therapies.

Purchase this report before year end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=biomarker-discovery-market?sindhuri
(Purchase 2 or more Reports and get 50% Discount)

Market Segmentation Analysis
By Product Type: Consumables dominate with 55.5% market share in 2024.
By Technology: Genomics leads with 35.3% market share in 2024.
By Application: Drug discovery, diagnostics, personalized medicine, and others.
By End-User: Pharmaceutical & biotechnology companies, CROs, academic & research institutes, and others.
Regional Insights
North America leads with 48.5% market share due to advanced healthcare infrastructure, strong biotech presence, and high investments in precision medicine. Asia-Pacific is the fastest-growing region, driven by increasing disease burden, government support, and expanding R&D in omics technologies.

Growth Drivers
Advancements in multi-omics and integrative biomarker approaches
Rising demand for precision medicine and companion diagnostics
Technological progress in NGS, mass spectrometry, and high-throughput screening
Increasing focus on early disease detection and personalized therapies
Growing R&D investments and strategic collaborations

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/biomarker-discovery-market?sindhuri

Key Players
The market includes leading companies such as Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, Abcam Limited, Olink, SomaLogic, and BD.

Key Highlights (Top 5 Key Players)
1. Thermo Fisher Scientific Inc. - Leading in instruments, reagents, and end-to-end multi-omics workflows for biomarker discovery.
2. Illumina, Inc. - Dominating genomics with advanced NGS platforms for genetic biomarker identification.
3. Agilent Technologies, Inc. - Innovating in mass spectrometry and high-throughput solutions.
4. Bio-Rad Laboratories, Inc. - Advancing proteomics and assay technologies for biomarker validation.
5. F. Hoffmann-La Roche Ltd - Strengthening companion diagnostics and personalized medicine applications.

Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?sindhuri
Power your decisions with real time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply Chain Analysis
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.